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Abstract 
Monocyte-derived macrophages (MoMØ) and monocyte-derived dendritic cells (MoDC) are 
two model systems well established in human and rodent systems that can be used to study 
the interaction of pathogens with host cells. Porcine reproductive and respiratory syndrome 
virus (PRRSV) is known to infect myeloid cells, such as macrophages (MØ) and dendritic 
cells (DC). Therefore, this study aimed to establish systems for the differentiation and 
characterization of MoMØ and MoDC for subsequent infection with PRRSV-1.  
M-CSF differentiated monocyte-derived macrophages (MoMØ) were stimulated with 
activators for classical (M1) or alternative (M2) activation. GM-CSF and IL-4 generated 
monocyte-derived dendritic cells (MoDC) were activated with the well established 
maturation cocktail containing PAMPs and cytokines. In addition, MoMØ and MoDC were 
treated with dexamethasone and IL-10, which are known immuno-suppressive reagents. Cells 
were characterized by morphology, phenotype and function and porcine MØ subsets 
highlighted some divergence from described human counterparts, while MoDC, appeared 
more similar to mouse and human DCs.  
The infection with PRRSV-1 strain Lena demonstrated different replication kinetics between 
MoMØ and MoDC and within subsets of each cell type. While MoMØ susceptibility was 
significantly increased by dexamethasone and IL-10 with an accompanying increase in 
CD163/CD169 expression, MoDC supported only a minimal replication of PRRSV These 
findings underline the high variability in the susceptibility of porcine myeloid cells towards 
PRRSV-1 infection.  
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Introduction 10 
Myeloid cells differentiate into various types of mononuclear phagocytic cells among them 11 
macrophages (MØs) and dendritic cells (DCs). In order to facilitate a range of complex 12 
functions, both MØs and DCs demonstrate phenotypic and functional heterogeneity 13 
according to their activation or maturation state. It is the pathogen/disease situation and 14 
signals from the surrounding microenvironment, which determine the state of MØs and DCs, 15 
resulting in several subsets that in turn determine the disease outcome. The study and 16 
characterization of myeloid cells is, therefore, an essential starting point in understanding 17 
virus kinetics and interactions with host cells. Current understanding of myeloid cells is based 18 
on studies using human cells or mouse models, whereas other species are not characterized to 19 
the same extent. Since important differences have been highlighted between mouse and 20 
human myeloid cell systems, the understanding of myeloid cells is equally important to aid 21 
the understanding of veterinary diseases. 22 
Activated MØs contribute to specific functional roles within the immune response (Gordon 23 
and Taylor, 2005). Two MØsubsets are recognized, referred to as M1 and M2, which result 24 
from classical or alternative activation respectively (Nathan, 1991; Gordon, 2003). Classical 25 
(M1) activation of MØrequires two signals, namely IFN-γ and TLR ligation (Mosser, 2003), 26 
and can be generated in vitro using IFN-γ and LPS (Nathan, 1991; Held et al., 1999). M1 27 
macrophages are able to kill intracellular pathogens (Mosser and Edwards, 2008), and 28 
produce a several pro-inflammatory cytokines including IL-1β, TNF, IL-6, IL-12 and IL-23 29 
(Verreck et al., 2004; Mantovani et al., 2005). In response to LPS, mouse M1 produce 30 
inducible nitric oxide synthase (iNOS) (MacMicking et al., 1997), whereas human 31 
macrophages do not (Thoma-Uszynski et al., 2001).  32 
Alternative (M2) activation of macrophages occurs via IL-4 or IL-13 (Stein et al., 1992). 33 
Resulting macrophages show increased mannose receptor expression (CD206) and are 34 
distinct from M1 MØs by their limited killing ability (Modolell et al., 1995). M2 MØs are 35 
associated with wound repair (Gordon, 2003), producing components for extracellular matrix 36 
synthesis (Gratchev et al., 2001). Other alternative activation of macrophages occurs with IL-37 
10, glucocorticoids and vitamin D3. Although the ‘M2’ nomenclature is often also applied to 38 
these cells, they show little similarity with IL-4/IL-13 M2 activated MØs (Mantovani et al., 39 
2004). 40 
Myeloid DCs also exist as different subsets according to their activation. In tissues, DCs 41 
reside in immature state, unable to stimulate T-cells. Immature DCs (iDCs) are well equipped 42 
for antigen uptake via phagocytosis (Svensson et al., 1997), macropinocytosis (Sallusto et al., 43 
1995) or receptor-mediated endocytosis (Sallusto and Lanzavecchia, 1994; Jiang et al., 44 
1995), but maturation of DCs and accessory signals (e.g. CD80/86) required for T-cell 45 
activation are necessary for primary immune responses. DC maturation occurs by way of 46 
‘danger signals’. This can be mimicked in vitro using a cocktail of factors including TLR 47 
ligands, such as LPS, inflammatory cytokines (TNF-α, IL1-β and IL-6) and molecules 48 
released following tissue damage such as prostaglandin E2 (PGE2) (Scandella et al., 2002; 49 
Jeras et al., 2005).  50 
Significant differences have also been identified between mouse and human DC subtypes 51 
(Vereyken et al., 2011). Comparative analysis suggests that the pig’s immune system is more 52 
closely resembled that of the human (Schook et al., 2005), but pigs are important in their own 53 
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right as the most important meat producing mammalian livestock species worldwide, and 54 
host to several pathogens, including zoonoses.  55 
An important disease of swine is porcine reproductive and respiratory syndrome (PRRS), 56 
caused by the virus PRRSV, which infects cells of myeloid lineage (Snijder and Meulenberg, 57 
1998), the proposed targets being alveolar macrophages and other tissue macrophages, but 58 
less monocytes and DCs (Haynes et al., 1997; Van Gorp et al., 2008). PRRSV belonging to 59 
genus Arterivirus (Snijder and Meulenberg, 1998; Meulenberg, 2000) is responsible for 60 
respiratory disease in pigs and reproductive failure in sows, affecting the swine industry 61 
worldwide (Hopper et al., 1992; Done and Paton, 1995; Rossow, 1998). Having emerged in 62 
North America during the late 1980s, PRRSV was identified in Europe shortly afterwards 63 
(Lindhaus and Lindhaus, 1991). PRRSV-1 (European) and PRRSV-2 (North American), 64 
cause a similar syndrome, despite sharing only 55-70% nucleotide identity (Forsberg et al., 65 
2002), which has led to the suggestion to consider these as separate virus species. Sequence 66 
analysis of PRRSV-1 strains defined at least three distinct subtypes, namely subtype 1 (pan-67 
European) and Eastern European subtypes 2 and 3 (Stadejek et al., 2008; Stadejek et al., 68 
2013). PRRSV isolates show significant differences in virulence and highly pathogenic (HP) 69 
PRRSV strains first arose in PRRSV-2 strains (Tong et al., 2007), but were since also 70 
identified in PRRSV-1 subtype 3 such as strains Lena and SU1-Bel (Karniychuk et al., 2010; 71 
Morgan et al., 2013; Weesendorp et al., 2013). 72 
PRRSV has a restricted cell tropism and infection of porcine alveolar macrophages is well 73 
described in vitro and in vivo (Haynes et al., 1997; Gomez-Laguna et al., 2013), although 74 
variability in macrophage susceptibility was observed in vitro (Duan et al., 1997a; Vincent et 75 
al., 2005) and peritoneal macrophages as well as macrophage precursor cells, i.e. bone 76 
marrow cells and peripheral blood monocytes, are reportedly refractory to PRRSV infection 77 
(Duan et al., 1997a;b; Teifke et al., 2001). PRRSV has been detected in or isolated from 78 
macrophages of various tissues, including the spleen, liver, Peyer's patches, thymus and 79 
placenta (Larochelle et al., 1996; Sur et al., 1996; Duan et al., 1997a;b; Lawson et al., 1997; 80 
Karniychuk and Nauwynck, 2009). In contrast, PRRSV infection of DCs is poorly 81 
understood and there are possibly significant differences between PRRSV-1 and -2. PRRSV-82 
2 infection of monocyte-derived DCs (MoDC) is frequently described (Wang et al., 2007; 83 
Flores-Mendoza et al., 2008; Park et al., 2008) and infection of bone marrow derived DCs 84 
(BMDC) was apparent (Chang et al., 2008), whereas reports of PRRSV-1 infection of DCs 85 
are very few (Silva-Campa et al., 2010).  86 
It was hypothesized that PRRSV is able to elicit immunosuppression (Drew, 2000; Diaz et 87 
al., 2005), although no direct evidence of such by PRRSV-1 exists to date (Mateu and Diaz, 88 
2008). More detailed reviews of host interactions with PRRSV-1 conclude that most PRRSV-89 
1 strains initiate weak innate immune responses, resulting in prolonged viremia and persistent 90 
infection , whereas strains that induce a significant inflammation are cleared more effectively 91 
(Morgan et al., 2013; Weesendorp et al., 2013; Salguero et al., 2015). However, previous in 92 
vitro studies of PRRSV-2 imply that it impairs DC function directly by modulation of 93 
important molecules, including the down-regulation of MHC-I and MHC-II (Wang et al., 94 
2007; Park et al., 2008). This suggested PRRSV-2 infected DCs were less efficient at 95 
presenting antigens to T cells. 96 
Although well described in humans and mice, differentiation of monocytes to Ms in vitro is 97 
not well established for pigs, although studies using L929-conditioned media as a source of 98 
M-CSF indicate its feasibility (Mayer, 1983; Genovesi et al., 1990) and human M-CSF has 99 
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been used to generate porcine macrophages from bone marrow (Kapetanovic et al., 2012), 100 
which expressed macrophage markers (CD14, CD16 and CD172a), and were phagocytic. 101 
Indicative of classical activation, these responded to LPS treatment by TNF-α production, but 102 
like human M1 Ms, lack NO production (Kapetanovic et al., 2012). Monocyte-derived 103 
macrophages (MoMØ) showed an altered phenotype compared to monocytes, including the 104 
expression of porcine macrophage marker CD203a (McCullough et al., 1997;McCullough et 105 
al., 1999). Few studies of porcine M1 and M2 phenotypes generated from MoMØ have yet 106 
been carried out, and it is important to further characterize porcine macrophages (Ezquerra et 107 
al., 2009).   108 
In vitro generation of DCs from monocytes (MoDC) using growth factor granulocyte 109 
macrophage-colony stimulating factor (GM-CSF) and IL-4 is established in various species, 110 
including cats (Mizukoshi et al., 2009), horses (Moyo et al., 2013) and cattle (Howard et al., 111 
1999). Porcine MoDC generation from was reported before, using slightly different 112 
conditions (Carrasco et al., 2001;Paillot et al., 2001).  113 
PRRSV-1 entry is thought to occur via receptor-mediated endocytosis. CD163 and 114 
sialoadhesin (CD169) were considered essential for PRRSV-1 entry in macrophages (Van 115 
Breedam et al., 2010a). CD169, a type 1 transmembrane protein restricted to macrophages 116 
(Munday et al., 1999), directly binds to sialic acids present on M/GP5 glycoprotein 117 
complexes in the PRRSV envelope. Transfection of CD169 into non-permissive cell lines 118 
enabled PRRSV attachment and internalization via endocytosis (Vanderheijden et al., 2003; 119 
Van Breedam et al., 2010b), but not productive infection, suggesting that an additional factor 120 
was required. CD163, also a type 1 transmembrane glycoprotein expressed mainly on certain 121 
monocytes and macrophages (Hogger et al., 1998), is implicated in later stages of PRRSV 122 
entry (Van Breedam et al., 2010a), considered essential for genome release, potentially 123 
requiring interaction with the minor envelope glycoproteins GP2a and GP4 (Das et al., 2010).  124 
As investigations of MoMØ and MoDC subsets in pigs remain elusive, our aim was to 125 
describe both cell types in vitro, distinguishing different sub-populations by phenotypical and 126 
functional analysis, and using them to assess how these cells react to PRRSV-1 infection with 127 
a highly pathogenic strain (Lena).  128 
 129 
Materials and methods 130 
Porcine myeloid cell isolation and culture  131 
All porcine primary cells were collected from Large White cross Landrace pigs under the age 132 
of 2 years.  All work was carried out under license from the UK Home Office (PPL 70/7057) 133 
under the Animal Act 1986 and approved by the ethics committee at APHA. Briefly, 134 
approximately 200 ml of venous blood was collected into sterile duran bottles containing 25 135 
IU of heparin sodium (LEO, Ballerup, Denmark) to prevent blood coagulation. Each 30 ml 136 
was layered onto 20 ml Biocoll separating solution, 1.077 g/ml density (Biochrom, Berlin, 137 
Germany) and centrifuged at 1455 g for 30 minutes at room temperature. The peripheral 138 
blood mononuclear cell (PBMC) interface was removed and washed with 4°C Dulbecco’s 139 
PBS (PBS) (Invitrogen, Paisley, UK). PBMC were counted and resuspended in 10 μl anti-140 
human CD14 MicroBeads (Miltenyi Biotec, Gergisch Gladbach, Germany) per 10
7
 cells and 141 
incubated at room temperature for 12 minutes. After washing with PBS + 2% fetal bovine 142 
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serum (FBS), cells were resuspended in 500 μl PBS + 2% FBS + 5 mM EDTA (Sigma, 143 
Poole, UK) (MACS buffer) per 10
8
 cells and applied to a MACS LS column placed on a 144 
magnetic quadro MACS unit (Miltenyi Biotec). Flow through was collected as the CD14
-
 145 
fraction and after washing the column with MACS buffer, the CD14
+
 fraction was collected 146 
in RPMI-1640 media + 10% FBS, 100 IU/ml of penicillin, 100 g/ml of streptomycin, and 50 147 
g/ml of gentamycin (all Invitrogen) (complete tissue culture [TC] medium) and cultured on 148 
ultra-low bind (ULB) plates at 37°C with 5% CO2. 149 
For differentiation of monocytes to MoMØ, freshly isolated monocytes were cultured at a cell 150 
density of 1x10
6
/ml in complete TC medium supplemented with 50 ng/ml of recombinant 151 
human M-CSF (Miltenyi Biotec) for 4 days. For differentiation of monocytes to MoDC, 152 
freshly isolated monocytes were cultured at a cell density of 2x10
6
/ml (1 ml/well) in complete 153 
TC medium supplemented with 10 ng/ml of recombinant porcine GM-CSF and 10 ng/ml of 154 
recombinant porcine IL-4 (R&D Systems, Abingdon, UK) for 4 days. Cell differentiation was 155 
monitored by assessment of cell morphology using light microscopy and phenotypic and 156 
functional characterization. 157 
For MoMØ activation , culture medium was replaced after 4 days with fresh TC medium 158 
containing 10 ng/ml of lipopolysaccharide (LPS) (from Salmonella Minnesota) (Enzo Life 159 
Sciences, Exeter, UK) and 100 ng/ml of recombinant porcine IFN-γ (R&D Systems) for 160 
classical activation of MoMØ (M1 macrophages). For alternative activation (M2 161 
macrophages), 10 ng/ml of recombinant porcine IL-4 was added. Alternatively MoMØ were 162 
also treated with 10 μg/ml of water soluble dexamethasone (Sigma) or 10 ng/ml of 163 
recombinant porcine IL-10 (R&D Systems) for 24 hours. 164 
MoDCs were treated with a maturation cocktail for 24 hours. This contained 100 ng/ml of 165 
LPS (Salmonella Minnesota), 100 ng/ml of porcine IFN-γ, 20 ng/ml of porcine TNF-, 20 166 
ng/ml of equine IL-6, 10 ng/ml of equine IL-1, and 1 µg/ml of PGE2 (all R&D Systems).  167 
 168 
Functional assays 169 
Endocytosis was assessed using allophycocyanin (APC)-labelled ovalbumin (OVA) 170 
(Invitrogen). Cells were resuspended in cold TC medium and added to 96-well round bottom 171 
plates at 1x10
5
/well. APC-OVA was added to cells at 20 μg/ml and incubated for 1 hour at 172 
either 4°C (control) or 37°C. Cells without beads were used as a further negative control. 173 
Cells were washed three times with cold PBS, and stained for viability using LIVE/DEAD 174 
violet fixable dye (Invitrogen) before flow cytometric analysis.  175 
Phagocytosis was assessed using fluorescin isothiocyanate (FITC)-labelled sulfate 176 
FluoSpheres® microsphere particles (4 µm diameter) or FITC-labelled carboxylate-modified 177 
microspheres (1 μm diameter) (both Invitrogen). Cells were split between two wells of a 24-178 
well ULB plate to allow for a control well without particles, and supplemented with 500 μl of 179 
fresh RPMI resulting in a cell density of 5x10
5
/ml. Microspheres were added at 2x10
5
 180 
beads/ml and incubated for 3 hours at either 4°C (control) or 37°C. Cells were then harvested 181 
and washed 3 times in cold PBS and subsequently stained for viability using LIVE/DEAD 182 
violet fixable dye before flow cytometric analysis. 183 
 184 
 185 
 186 
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Flow cytometry 187 
All flow cytometry was carried out using a MACSQuant Analyzer flow cytometer (Miltenyi 188 
Biotec). Antibodies were added to cell pellets following harvesting from plates and 189 
centrifugation. For elimination of dead cells, cells were resuspended in LIVE/DEAD violet 190 
fixable dye and incubated at RT for 20 minutes protected from light.  191 
For surface molecule staining , cells were added to round bottom 96-well plates 192 
(~5x10
5
/well) and stained with relevant antibodies (Table 1) at 4°C for 30 minutes before 193 
washing in PBS + 1% FBS + 0.09% sodium azide (FACS buffer). Single color stained cells 194 
and unstained cells were used to calculate compensation for fluorescence spill-over. 195 
Individual samples were also stained with isotype negative controls of corresponding 196 
concentration to the relative antibody where described. Prior to analysis, cells were 197 
resuspended in CellFix (BD Biosciences, Oxford, UK). 198 
For analysis of PRRSV infection cells were added to round bottom 96-well plates 199 
(~5x10
5
/well) before being fixed and permeabilized using the CytoFix/CytoPerm kit 200 
according to the manufacturer’s protocol (BD Biosciences). PRRSV specific monoclonal 201 
antibody SDOW-17 (Rural Technologies Inc, Brookings, USA) was diluted 1/20 in 202 
PermWash and 5 μl was added to each well and incubated for 30 minutes at 4°C. Anti-mouse 203 
IgG1 isotype control was used to assess for non-specific binding. Cells were washed twice, 204 
and stained with anti-mouse IgG1-APC conjugated secondary reagent (BD Biosciences). 205 
 206 
PRRSV-1 virus infection and detection  207 
PRRSV-1 strain Lena is a particularly pathogenic subtype 3 strain isolated from Belarus 208 
(Karniychuk et al., 2010) that was supplied by Prof. Hans Nauwynck (Ghent University, 209 
Ghent, Belgium). Virus was propagated and titrated on porcine alveolar macrophages prior to 210 
this study, as previously described (Morgan et al., 2013). Cells were infected with PRRSV-1 211 
strain Lena at a multiplicity of infection (m.o.i.) of 0.1. Time-zero samples were obtained 212 
following 2 hours of incubation with virus at 4°C to achieve attachment but no internalization 213 
of virus. At different time-points post infection (p.i.), cell supernatant was removed for 214 
analysis of infection by quantitative reverse transcriptase-polymerase chain reaction (qRT-215 
PCR) and cells were harvested and centrifuged to obtain cell pellets. Cell pellets or 216 
supernatants were stored at -70°C prior to RNA extraction. A QiaAmp Viral RNA Mini Kit 217 
(Qiagen, Manchester, UK) was used to extract RNA from 140 μl of cell supernatant, or cells 218 
resuspended in 140 μl AVL buffer. RNA was eluted into 60 μl of elution buffer and stored at 219 
-20°C prior to RT-PCR analysis. For PRRSV detection by qRT-PCR, 2 μl of RNA was added 220 
to 23 μl of a PCR mastermix containing PRRSV-1 specific forward/reverse primers and 221 
probe (Frossard et al., 2012) and the Quantitect RT-PCR Kit (Qiagen). For RNA extracted 222 
from cells, a eukaryotic 18S rRNA RT-PCR was used as endogenous control to allow 223 
normalization (Applied Biosystems, Paisley, UK). qRT-PCRs were carried out using a 224 
Mx3000P real time PCR system (Agilent, La Jolla, California) as described before (Morgan 225 
et al., 2013) 226 
To quantify PRRSV in cell supernatants, Ct values of PRRSV at 2 hours p.i. (i.e. time-zero 227 
negative control) were subtracted from Ct values of PRRSV detected at each time-point p.i., 228 
providing a Ct, which was transformed into a fold increase as a measure of replication. 229 
Alternatively, where replication was measured in cells, relative quantitation was used to 230 
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analyze changes between the time-zero negative control and time p.i., using normalization 231 
against 18S rRNA levels using the ΔΔCt method (Livak and Schmittgen, 2001). 232 
 233 
Statistical analysis 234 
Statistical tests were performed using GraphPad Prism Software, version 6.01. All 235 
experiments were performed independently at least 3 times using cells isolated from 3 236 
different pigs unless stated otherwise.  Statistical tests such as One-way or Two-way analysis 237 
of variance (ANOVA) and student t-tests were performed as detailed in the results 238 
 239 
Results 240 
Differentiation and characterization of monocyte-derived macrophages (MoMØ) 241 
After 4 days with M-CSF, monocytes developed macrophage morphology (enlarged, 242 
adherent, round). Upon treatment for 24 hours with LPS/IFN-γ (M1) these cells displayed 243 
increased formation of cell clusters, whereas IL-4 treated MoMØ (M2) had noticeably more 244 
elongated projections (Figure. S1). Surface expression of myeloid lineage and activation 245 
markers revealed that the percentage of M2 MoMØ expressing CD203a, was significantly 246 
higher than for unstimulated MoMØ (p<0.001) and M1 MoMØ (p<0.001), whereas 247 
expression of CD14, CD206, CD163 and CD169 remained unchanged (Figure 1A). However, 248 
MHC-II was detected on a significantly higher percentage of M1 MoMØ than on 249 
unstimulated MoMØ (p<0.0001) and M2 MoMØ (p<0.001) and the percentage of cells 250 
expressing CD80/86 was also significantly higher in M1 MoMØ, compared to unstimulated 251 
MoMØ (p<0.001) and M2 MoMØ (p<0.05). Further, more M1 MoMØ also expressed IL-2 252 
receptor alpha CD25 (p<0.05), whereas significantly less M1 MoMØ expressed CD209 (DC-253 
SIGN) than unstimulated MoMØ (p<0.001), and M2 MoMØ (p<0.001) (Figure 1B). CD83 254 
expression was unchanged between unstimulated and M1 or M2 MoMØ. Endocytic and 255 
phagocytic activity of porcine MoMØ (poMoMØ) following treatment with M1 or M2 256 
activators was also assessed, but no significant differences were observed (Figures S2, S3).  257 
Dexamethasone (dexa) and IL-10 were also applied to activate MoMØ. Light microscopy 258 
showed that dexa treated MoMØ appeared more rounded, with some enlarged cells compared 259 
to unstimulated MoMØ, while IL-10 treated MoMØ noticeably clustered together more 260 
frequently (Figure S1). Thus both dexa and IL-10 treated MoMØ appeared unlike M1 and 261 
M2 MoMØ supporting the notion that they are not M2 macrophages (Gordon, 2003; 262 
Mantovani et al., 2005). Dexa and IL-10 treatment of MoMØ also resulted in two distinct 263 
MoMØ phenotypes, both showing differences to M1 and M2 MoMØ phenotypes. Dexa 264 
treated MoMØ showed significantly higher percentages of cells expressing CD163 265 
(p<0.0001), as did IL-10 treated MoMØ (p<0.05), but the percentage of cells expressing 266 
CD163, was significantly higher in dexa MoMØ than IL-10 MoMØ (p<0.005). IL-10 treated 267 
MoMØ showed significantly higher percentages of cells positive for CD203a than 268 
unstimulated (p<0.001) and dexa treated MoMØ (p<0.05). No differences were observed in 269 
the percentage expression of CD206 or CD169 in dexa or IL-10 treated MoMØ (Figure 2A). 270 
No differences were observed in the MHCII expression, but a lower proportion of IL-10 271 
treated MoMØ expressed CD80/86 (p<0.05). Both dexa and IL-10 treatment of MoMØ 272 
resulted in a decreased percentage of cells expressing CD83 (both p<0.001), whereas no 273 
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differences were observed in the percentage of cells positive for CD25 or CD209 (Figure 274 
2B). Flow cytometric analysis determined that IL-10 treated MoMØ displayed significantly 275 
increased endocytosis (75.8%) compared with both dexa MoMØ (56.5%) and M2 MoMØ 276 
(57.2%) (p<0.05) (Figure S4). In 2 of 5 pigs, phagocytosing microsphere particles was also 277 
increased in dexa MoMØ (Figure S5).  278 
 279 
PRRSV-1 Lena infection of MoMØ subsets 280 
PRRSV-1 replication within MoMØ subsets was assessed by both qRT-PCR and flow 281 
cytometry at 16 hours p.i. Only dexa treatment showed a significant increase in PRRSV-1 282 
replication measurable by both methods (Figure 3, Figure S6). In contrast, neither classical 283 
(M1) nor alternative (M2) macrophage activation resulted in changes at this time-point. After 284 
16 hours p.i., PRRSV-1 replication in dexa treated macrophages did not seem to increase 285 
further, and other MoMØ reached similar replication levels by around 72 hours p.i. 286 
Interestingly, M1 MoMØ showed negative ΔΔCt values at 24 and 48 hours (Figure 3), 287 
indicating a major obstacle for PRRSV-1 replication. However, PRRSV-RNA was detected 288 
in M1 cells after 72 hours p.i. (Figure 3). In line with qRT-PCR results, only dexa MoMØ 289 
showed significant levels of PRRSV N protein expression (Figure S6). At 16 hours p.i., 290 
PRRSV-RNA levels in culture supernatants were low and no differences were observed 291 
between MoMØ subsets (Figure 4). At 20 hours p.i., clear differences started to emerge, i.e. 292 
dexa MoMØ produced the highest amount of PRRSV-1, while M1 MoMØ did not show any 293 
significant PRRSV-1 production until around 48 hours p.i.  294 
 295 
Characterization of porcine MoDC 296 
After 4 days with GM-CSF and IL-4, monocytes developed typical DC morphology, with cell 297 
clusters displaying surface protrusions.  24 hours culture with the standard maturation 298 
cocktail resulted in no significant morphological changes, although maturation cocktail 299 
treated MoDC were less adherent than untreated MoDC (Fig. S7). DC maturation cocktail did 300 
induce some significant changes to MoDC phenotype, however. A significant increase was 301 
observed in expression of both CD80/86 (p<0.001) and CD83 (p<0.001), while MHC-II 302 
expression remained high (Figure 5). The number of maturation cocktail treated MoDC 303 
expressing CD14 was significantly lower than on immature (i) MoDC (p<0.001); CD206 and 304 
CD209 (DC-SIGN) remained low, as did CD203a. The percentage of cells expressing CD163 305 
and CD169 was negligible in both untreated and treated MoDC (Figure 5B).  306 
Following 24 hours treatment with dexa, MoDC appeared to have fewer and less dense 307 
clusters than untreated MoDC, but still maintained cellular elongation. In contrast, IL-10 308 
treated MoDC appeared similar to untreated MoDC, with fewer cellular elongations (Fig. 309 
S7). Dexa treatment also resulted in a distinct MoDC phenotype, while IL-10 treatment rather 310 
maintained the iMoDC phenotype (Figure 6). Specifically the expression of CD1, CD14, 311 
CD206 and CD209 was up-regulated by dexa. Dexa MoDCs expressed almost twice as much 312 
CD14 and significantly more CD1 than maturation cocktail treated MoDC CD25 expression, 313 
however, was decreased following dexa treatment (p<0.0001). In contrast to MoMØ, neither 314 
dexa nor IL-10 treatment affected expression of CD163 and CD169 on MoDC; the 315 
percentage of cells expressing these molecules remained below 10%.  316 
P v
i ion
al
10 
 
Endocytosis was much lower in MoDC than observed in MoMØ. Percentages of cells 317 
associated with APC-OVA, indicative of endocytosis, were unchanged between iMoDC and 318 
mMoDC. In contrast, both dexa and IL-10 treatment of MoDC, appeared to increase 319 
endocytosis. However, replicate experiments were variable, and as a result only dexa treated 320 
MoDC showed a statistically significant increase in endocytic activity (p<0.05) (Figure 7). 321 
Levels of phagocytosis in MoDC subsets were also below those observed in MoMØ. Whilst 322 
maturation cocktail treatment did not induce changes, IL-10 treated MoDC showed 323 
statistically higher percentages of cells associated with FITC-labelled particles compared to 324 
iMoDC and mMoDC (p<0.05) (Figure 8). 325 
 326 
PRRSV Lena infection of MoDC subsets 327 
At 16 hours p.i. viral replication was generally low in MoDC, with dexa MoDC being 328 
particularly inefficient and mMoDC displaying a slightly higher replication level. At 24 hours 329 
p.i., viral replication appeared to increase but without showing significant differences 330 
between subsets (Figure 9). After 48 hours viral replication in some MoDC subsets showed 331 
slight increases particularly dexa MoDC and IL-10 MoDC, but these differences were not 332 
significant. In line with qRT-PCR results, no PRRSV protein expression could be detected by 333 
intracellular flow cytometry staining at 20 hours p.i. (not shown). At 16 hours p.i., PRRSV 334 
was undetectable in MoDC supernatants, indicating a longer time for a single round of virus 335 
replication in all MoDC (Figure 10). Only after 36 hours p.i. clear signs of viral production 336 
were seen in the supernatant of IL-10 and dexa treated MoDC, albeit at very low levels. This 337 
trend remained until the endpoint at 72 hours p.i., with some evidence of virus production in 338 
iMoDC, whereas mMoDC seemed to be particularly refractory to PRRSV replication 339 
(Figures 10). Due to variability between biological repeats, no statistically significant 340 
differences were observed between MoDC subsets.  341 
 342 
Discussion 343 
This study aimed to characterize subsets of macrophages and DCs derived from porcine 344 
monocytes, and to determine whether these cells could be used to explore PRRSV-1 infection 345 
kinetics within porcine myeloid cell sub-populations. 346 
 347 
Classical and alternative activation of porcine MoMØ 348 
Morphological and phenotypical analysis of porcine MoMØ (poMoMØ) treated with M1 349 
(IFN-γ and LPS) or M2 cytokines (IL-4) resulted in two distinct populations, which are 350 
suggestive of different MØ activation pattern.  Analysis of markers associated with classical 351 
and alternative activated macrophages in humans and mice suggested that despite some 352 
similarities, poMoMØ may not behave alike. Morphological changes were unexpected to be 353 
prominent, since human M1 and M2 macrophages lack any particular morphology (Porcheray 354 
et al., 2005; Vereyken et al., 2011). Our results align with this, as poMoMØ formed clusters 355 
suggestive of decreased adherence, consistent with Rey-Giraud et al (2012) who describe 356 
increased detachment of human M1 macrophages. IL-4 treated poMoMØ showed smaller cell 357 
clusters joined by long projections which, as a typical IL-4 effect, are well documented and 358 
consistent with IL-4 treated mouse macrophages (Vereyken et al., 2011), possibly 359 
contributing to increased motility for migration to inflammation sites (Gordon, 2003).  360 
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Activation of poMoMØ led to significant changes in phenotype. Up-regulation of MHC and 361 
co-stimulatory molecules was consistent with the increased APC role of M1 activated 362 
macrophages (Gordon and Taylor, 2005). MHC-II up-regulation is a known effect of IFN-γ 363 
(Schroder et al., 2004), and CD86 expression alike was described in M1 macrophages 364 
(Mosser, 2003; Gordon and Taylor, 2005; Whyte et al., 2011). In addition CD25 was 365 
significantly increased on stimulated M1 poMoMØ, which as previously noted is a result of 366 
LPS in human monocytes (Scheibenbogen et al., 1992).  367 
Important for migration (Geijtenbeek et al., 2000), DC-SIGN/CD209 expression is IL-4 368 
dependent, associated with M2 macrophages (Martinez et al., 2006) and negatively regulated 369 
by IFNs (Relloso et al., 2002). Whilst we found that CD209 was significantly down-regulated 370 
in M1 MoMØ, we did not see IL-4 effects observed in other species. CD203a, significantly 371 
up-regulated on porcine M2 MoMØ, is a homologue to the human NPP1/CD203α, which 372 
regulates mineralization in articular cartilage and arterial tissues (Bollen et al., 2000; Goding 373 
et al., 2003), relating to the role of M2 macrophages in tissue repair. 374 
Expression of both putative PRRSV-1 receptors CD163 and CD169 was unchanged in M1 or 375 
M2 MoMØ, which was particularly surprising in M2 MoMØ, given that others report this in 376 
human and mouse M2 macrophages, assumed to aid clearance of damaged cells (Gordon, 377 
2003).  378 
 379 
Dexa and IL-10 treatment of MoMØ results in two further MoMØ phenotypes 380 
Dexa and IL-10 induced morphological changes unlike those observed with IFN-γ/LPS and 381 
IL-4. The rounded appearance was comparable to a proposed ‘condensed’ morphology of 382 
dexa treated human macrophages (Porcheray et al., 2005), and consistent with the proposed 383 
deactivation state (Gordon, 2003). IL-10 induced only slight morphological changes, in 384 
agreement with Rey-Giraud et al (2012) who described unchanged morphology of IL-10 385 
treated human macrophages.  386 
Both dexa and IL-10 significantly decreased CD83 expression on MoMØ, whilst only IL-10 387 
decreased CD80/86. Decrease of maturation markers is in line with the assumption that both 388 
dexa and IL-10 are immunosuppressive. Whilst still poorly understood, deactivation is 389 
considered a final stage, halting inflammation and tissue damage (Gordon, 2003). Up-390 
regulation of CD203a was the only shared effect of IL-10 and IL-4, not shown before, and 391 
not a feature attributed to alternative activation. IL-10 significantly increased endocytosis, 392 
thereby suggesting that uptake was independent of CD206 expression. Both dexa and IL-10 393 
treatment significantly up-regulated CD163 in MoMØ, in line with the over-expression of 394 
CD163 described on differentiated macrophages treated with dexa and IL-10 (Porcheray et 395 
al., 2005). 396 
Whilst earlier studies (Stein et al., 1992; Rey-Giraud et al., 2012) demonstrate increased 397 
endocytic and phagocytic activity in M2 macrophages, an increase was also observed in 398 
classically activated mouse macrophages (Vereyken et al., 2011). While neither M1 nor M2 399 
treatment of poMoMØ significantly altered antigen uptake, dexa enhanced phagocytosis and 400 
IL-10 enhanced endocytosis. IL-10 has been shown to enhance endocytic activity of porcine 401 
macrophages (Montoya et al., 2009) and MoDC (Longoni et al., 1998). While early reports 402 
suggest that dexa suppresses macrophage phagocytic activity (Becker and Grasso, 1985), our 403 
result is in line with more recent studies using human MoMØ where dexa enhanced 404 
phagocytosis (Zahuczky et al., 2011).  405 
P ov
i i n
l
12 
 
 406 
PRRSV-1 susceptibility varies across different MoMØ subsets 407 
Previous studies have suggested that differences in disease susceptibility between pig breeds 408 
or individuals within pig breeds are correlated with differences in macrophage activation 409 
states (McCullough et al., 1993; Duan et al., 1997a; Ait-Ali et al., 2007).  410 
Unchanged CD163 and CD169 expression following classical and alternative activation of 411 
MoMØ suggested that M1 or M2 MoMØ susceptibility to PRRSV-1 would be unaffected. 412 
We did not expect M1 macrophages to show such low replication levels. This failure, 413 
eventually overcome after 3 days, could be linked with the anti-viral effect of IFN-γ, which 414 
inhibits PRRSV-1 replication in vitro (Bautista and Molitor, 1999; Rowland et al., 2001).  415 
Dexa significantly enhanced PRRSV-1 replication in MoMØ, associated with increased 416 
CD163 expression. Interestingly, dexa did not increase CD169, presumed the first receptor 417 
for PRRSV attachment (Calvert et al., 2007). Dexa’s ability to increase PRRSV replication 418 
with a significant effect on CD163 alone could suggest that CD169 was already sufficient 419 
before activation, or that it has no role in PRRSV, as suggested by Prather et al (2013).  420 
All MoMØ subsets appeared to increase their virus production into cell supernatant over 421 
time, however the only significant differences observed between time-points were with IL-10 422 
and dexa treatment up to 48 hours p.i.. Our data supports previous suggestions that one round 423 
of PRRSV replication in alveolar macrophages takes 9-16 hours (Morilla, 2002), and 424 
suggests that further replication may have occurred subsequently.   425 
Flow cytometric staining of PRRSV nucleocapsid protein was detected in dexa MoMØ only, 426 
which may be due to the low initial m.o.i. of 0.1. This was unexpected, since macrophages 427 
are considered the most favorable cell for PRRSV-1 tropism, where over time we expected a 428 
higher replication and spread through the culture. However, Thacker et al (1998) detected 429 
only up to 38% of PRRSV-2 infected macrophages, using a m.o.i. of 1 (Thacker et al., 1998). 430 
It is thus reasonable to question if differentiated MØ are truly highly permissive for PRRSV.  431 
 432 
Porcine MoDC show a mature phenotype in response to cytokine activation cocktail  433 
Porcine MoDC differentiation has been described before (Paillot et al., 2001; Chamorro et 434 
al., 2004) and the morphology observed here fully aligned with previous reports and studies 435 
in other species (Miranda de Carvalho et al., 2006; Moyo et al., 2013). Similarly, poMoDC 436 
maturation is well established and molecules involved in antigen presentation were up-437 
regulated as described in response to LPS alone (Carrasco et al., 2001; Flores-Mendoza et al., 438 
2008; Facci et al., 2010), or a LPS/IFN-γ/TNF-α cocktail (Pilon et al., 2009).  439 
CD1a and CD1b are considered hallmark human DC phenotypes (Cao et al., 2002; Dascher 440 
and Brenner, 2003). Here, in pigs, CD1 expression was unchanged following maturation, 441 
which is consistent with a previous report (Carrasco et al., 2001). It should be noted, 442 
however, that CD1 diverged evolutionarily and appears in various isoforms differing between 443 
species. While the pig CD1 locus is described (Eguchi-Ogawa et al., 2007), we are unaware 444 
which CD1 molecule is detected by the antibody used. 445 
Whilst CD83 is a known marker of DC maturation in both humans (Zhou and Tedder, 1996) 446 
and mice (Berchtold et al., 1999), recent studies highlight species differences regarding 447 
MoDC CD83 expression (Moyo et al., 2013). Although the expression was significantly up-448 
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regulated with maturation cocktail, CD83 expression in iMoDCs suggests that pigs are more 449 
similar to horses and unlike humans or mice which do not express CD83 on iMoDCs. CD206 450 
expression is reportedly hallmark of human iDCs, absent on monocytes and mDC (Sallusto 451 
and Lanzavecchia, 1994; Mellman et al., 1998; Cochand et al., 1999), however it would 452 
appear that porcine MoDCs (poMoDCs) are again different and rather similar to horses, 453 
where its modulation on MoDC is variable (Mauel et al., 2006). 454 
CD14, a marker of monocytes and macrophages, not expressed by human blood-DCs 455 
(Thomas et al., 1993), was expressed by poMoDCs and decreased following maturation. 456 
CD14 is also expressed in MoDCs in other species including cat, cattle and dog (Miranda de 457 
Carvalho et al., 2006). Some poMoDC studies (Paillot et al., 2001; Chamorro et al., 2004) 458 
suggest the absence of CD14 following maturation, although Carrasco et al (2001) report 459 
increased CD14 following MoDC maturation (Carrasco et al., 2001). Such discrepancy could 460 
be owing to differences in the differentiation protocol. Carrasco et al (2001) used autologous 461 
porcine serum for differentiation, often used for differentiation of macrophages, and these 462 
cells may have maintained some MoMØ characteristics.  463 
 464 
Porcine MoDC respond to IL-10 and dexamethasone by modulation of phenotype and 465 
function 466 
Whilst little was known about the effects of dexa on poMoDC prior to this study, reports 467 
suggested that glucocorticoids impair human MoDC differentiation and maturation (Woltman 468 
et al., 2000; Bengtsson et al., 2004), and that IL-10 induces a regulatory subset of DCs 469 
(Velten et al., 2004).  470 
Dexa induced significant changes to MoDC phenotype, resulting in a phenotype unlike 471 
iMoDC nor mMoDC. MHC-II expression remained high, while the phenotype was otherwise 472 
inconsistent with maturation, also found to occur in human MoDCs treated with dexa 473 
(Duperrier et al., 2005). Differences between CD80/86 and CD83 positive cells in mMoDC 474 
and dexa MoDC support the theory that dexa inhibits maturation, as does our finding that 475 
dexa MoDCs express significantly increased CD14, exceeding that of porcine MoMØ. This 476 
finding aligns with other studies (Piemonti et al., 1999; Canning et al., 2000; Duperrier et al., 477 
2005), and strengthens suggestion of an altered status. Importantly, CD163 and CD169 478 
expression by poMoDC remained negligible following DC treatment with either dexa or IL-479 
10. Unlike dexa, IL-10 failed to significantly modulate the MoDC phenotype, in line with IL-480 
10 inhibition of human DC maturation (Buelens et al., 1997).  481 
Despite variable endocytosis and phagocytosis, due to variability amongst animals, a 482 
significant difference was observed between the endocytic activity of dexa MoDC and 483 
iMoDC, and IL-10 increased phagocytic activity of poMoDCs, consistent with the increased 484 
antigen capture ability described in human IL-10-treated MoDCs, which maintain iMoDC 485 
characteristics (Morel et al., 1997). Increased endocytic activity was also described in 486 
humans (Longoni et al., 1998) and although not significant, our data confirm a trend to this 487 
effect.  488 
 489 
Infection of porcine MoDC subsets with PRRSV-1 490 
PRRSV-1 replication in iMoDC remained low throughout the observation period of 72 hours 491 
in both cells and cell supernatant. Another PRRSV-1 MoDC infection study also highlights 492 
variation between virus strains (Silva-Campa et al., 2010), suggesting that a strain specific 493 
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feature of Lena might be to replicate poorly in MoDC. Interestingly, the same study suggests 494 
that DCs remain in an immature state following infection, as shown for PRRSV-2 strains 495 
(Wang et al., 2007; Flores-Mendoza et al., 2008), denoting that PRRSV favors replication in 496 
iMoDCs, consistent with data obtained here. It should be considered, however, that the 497 
maturation cocktail used contained IFN-γ, the anti-viral effects of which were discussed 498 
above.  499 
Virus was not detected in supernatant until 24 hours p.i., which mirrored the time-point 500 
where infection peaked in cells and indicated a significantly slower replication rate than in 501 
MoMØs. Interestingly, both dexa and IL-10 MoDCs reached peak virus replication even 502 
later. Absence of CD163 and CD169 on MoDCs, and the ability to infect such cells in 503 
principle, indicates that PRRSV infection of DCs may involve receptors not yet identified. It 504 
could be considered that DCs might become infected through uptake of bystander infected 505 
apoptotic cells. This, proposed by others (Frydas et al., 2013), would require further 506 
investigation using mixed cell cultures to demonstrate MoDCs infection as a consequence of 507 
other susceptible cells present. Whilst slow viral growth of PRRSV-2 has been associated 508 
with older pigs with increased viral resistance (Klinge et al., 2009Klinge et al., 2009), it is 509 
unlikely to explain the low infection levels observed in MoDCs here, since monocytes from 510 
the same animals showed high infection in parallel experiments. 511 
In summary, PRRSV-1 is able to replicate in porcine myeloid cells in various states of 512 
activation or maturation, however, replication is much slower in MoDCs than in MoMØs. 513 
Dexa and IL-10 were both shown to promote PRRSV replication in macrophages, but failed 514 
to influence MoDCs in the same manner. Both IL-10 and dexa are known to act on MoDCs, 515 
but their inability to modulate CD163 and CD169 on these cells specifically makes up-516 
regulation of these the most likely action by which PRRSV-1 replication is increased. Further 517 
investigation using a higher m.o.i. and measuring viral proteins in combination with CD163 518 
and CD169 would be required to determine co-localization. Reports describing IL-10 519 
production by PRRSV as a mechanism of immune suppression have been discussed 520 
controversially (Suradhat et al., 2003; Díaz et al., 2006). Our findings suggest an additional 521 
role of IL-10 in promoting PRRSV-1 replication. Given that DCs are considered the most 522 
professional APCs, the slow and inefficient infection of MoDCs may also explain the delay 523 
in T-lymphocyte response to PRRSV, possibly providing PRRSV with an elegant immune 524 
evasion mechanism.  525 
 526 
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Table 1: 960 
Table of antibodies 961 
 962 
Antibody Host Species Target 
Species 
Clone Isotype Conjugate Supplier 
Primary antibodies       
SLA Class II DR Mouse Pig 2E9/13 IgG1 FITC AbD Serotec 
CD14 Mouse Pig MIL-2 IgG2b FITC AbD Serotec 
CD163 Mouse Pig 2A10/11 IgG1 FITC AbD Serotec 
CD169 Mouse Pig 3B/11/11 IgG1 Unconjugated AbD Serotec 
CD152-muIg (CTLA4) Mouse Human  IgG2a Unconjugated Enzo Life Sciences 
CD25 Mouse Pig K231.3B2 IgG1 Unconjugated AbD Serotec 
CD206 (-MMR) Goat Human  Polyclonal Biotinylated R&D Systems 
CD209 (DC-SIGN) Sheep Human  Polyclonal Unconjugated R&D Systems 
CD83 Sheep Human  Polyclonal Biotinylated R&D Systems 
SWC9 Mouse Pig PM 18-7 IgG1 Unconjugated Abcam 
SDOW-17 Ascites Mouse Pig  IgG1 Unconjugated Rural Technologies 
Secondary Antibodies       
G1-APC Rat Mouse X56  APC BD Biosciences 
Donkey anti-goat IgG Donkey Goat   APC Invitrogen 
Donkey anti-sheep IgG Donkey Sheep   APC Invitrogen 
Sterptavidin-PE-Cy7     PE-Cy7 eBiosciences 
Alexa Fluor Zenon 
Conjugates 
      
IgG1 APC     APC Life Technologies 
IgG2a APC     APC Life Technologies 
IgG1 PE     PE Life Technologies 
 963 
  964 
Prov
ision
al
26 
 
Figure 1. Phenotypical analysis of porcine M1 and M2 MoMØs.  Freshly isolated 965 
peripheral porcine monocytes were treated with M-CSF for 4 days to obtain MoMØs. 966 
MoMØs were treated with IFN-γ and LPS to generate M1 macrophages (blue) or with IL-4 967 
to generate M2 macrophages (orange), or MoMØs were left unstimulated (unfilled bars). 968 
After a further 24 hours MoMØ were harvested and stained with various antibodies to assess 969 
their surface expression of pathogen recognition receptor/lineage markers (A) or antigen 970 
presentation/co-stimulatory molecules (B) for flow cytometry analysis. Data represent mean 971 
percentage of cells expressing markers +SD. One-way ANOVA was used to assess 972 
significance followed by Bonferroni’s multiple comparison test ***p<0.0001, **p<0.001, 973 
*p<0.05. 974 
 975 
Figure 2. Phenotypic analysis of dexa and IL-10 treated MoMØs. Freshly isolated 976 
peripheral porcine monocytes were treated with M-CSF for 4 days to obtain MoMØs. 977 
MoMØs were treated with dexa (blue) or IL-10 (orange) or left unstimulated (unfilled bars). 978 
After a further 24 hours MoMØs were harvested and surface stained for pathogen recognition 979 
receptors/lineage markers (A) or antigen presentation/co-stimulatory molecules (B) for flow 980 
cytometric analysis. Data represent mean percentage of cells expressing markers +SD. One-981 
way ANOVA was used to assess significance followed by Bonferroni’s multiple comparison 982 
test ***p<0.0001, **p<0.001, *p<0.05. 983 
 984 
Figure 3. PRRSV replication in MoMØs following different activation stimuli.  985 
Monocytes were treated with M-CSF for 4 days to generate MoMØs, and either left 986 
unstimulated (red) or activated with LPS & IFN-γ (M1) (pink), IL-4 (M2) (green), dexa 987 
(orange) or IL-10 (blue)  for 24 hours before infection with PRRSV Lena using an m.o.i of 988 
0.1.  RNA was extracted from cells at either 16, 24, 48 or 72 hours p.i, and a TaqMan qPCR 989 
was used to quantify PRRSV RNA.  ΔΔCt represents difference between Ct at 2 hours p.i 990 
(time zero) and Ct at each time point p.i after normalization against 18S RNA. Bars represent 991 
mean ΔΔCt +SD. 992 
 993 
Figure 4.  PRRSV replication in MoMØ subset supernatant over time. Monocytes were 994 
treated as in Figure 3. Viral RNA was extracted from cell supernatant at 16, 20, 24, 36, or 48 995 
hours p.i, and a TaqMan qPCR was used to obtain Ct values. ΔCt represents difference 996 
between Ct at 2 hours p.i (time zero) and Ct at each time point p.i shown at 16, 20, 24, 36, 48, 997 
or 72 hour time-points in unstimulated (red), M1 (pink) M2 (green), dexa (blue) or IL-10 998 
(orange) treated MoMØs. Lines represent mean ΔCt ± SD in 3 independent experiments, 999 
each biological repeat tested in duplicate (n=2 at 72 hr p.i). 1000 
 1001 
Figure 5.  The effect of maturation cocktail on porcine MoDC. 4 day old MoDC were 1002 
treated with a maturation cocktail for 24 hours before flow cytometric analysis of surface 1003 
molecules involved in DC maturation or antigen presentation (A) and other co-stimulatory 1004 
molecules and lineage markers (B) in untreated iMoDC (white bars) and cytokine maturation 1005 
cocktail treated (blue bars) MoDCs. Bars show mean percentage of cells expressing each 1006 
marker +SD . Two-way ANOVA was used to assess significance followed by Bonferroni’s 1007 
multiple comparison test, **p<0.001. 1008 
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Figure 6.  The effects of dexamethasone and IL-10 treatment on the phenotype of 1009 
porcine MoDCs. 4 day old MoDCs were treated with either dexamethasone or IL-10 for 24 1010 
hours before surface staining with various anti-porcine or anti-human mono/poly-clonal 1011 
antibodies for flow cytometric analysis of surface molecules involved in antigen presentation 1012 
and maturation (A) or against other co-stimulatory molecules and myeloid lineage markers 1013 
(B) in untreated MoDCs (unfilled bars), dexa treated MoDCs (blue bars), or IL-10 treated 1014 
MoDCs (orange bars). Bars show mean percentage of cells expressing each marker +SD (A, 1015 
B). One-way ANOVA was used to assess significance followed by Bonferroni’s multiple 1016 
comparison test ***p<0.0001, **p<0.001, *p<0.05. 1017 
 1018 
Figure 7. The effect of dexa treatment on MoDC levels of endocytosis. The ability of 1019 
immature/iMoDC (untreated), mature/mMoDC (maturation cocktail treated) to endocytose 1020 
APC*-labelled OVA was assessed. Cells were incubated with OVA at 4°C as a negative 1021 
control (blue dots), or at 37°C (red dots), for 1 hour before flow cytometric analysis of 1022 
APC* fluorescence.  Each dot represents the percentage of cells fluorescing APC*, indicating 1023 
endocytic OVA uptake, in individual experiments. Lines represent mean percentages of cells 1024 
associated with OVA-APC* ±SEM . One-way ANOVA was used to assess significance 1025 
followed by Bonferroni’s multiple comparison test, *p<0.05. 1026 
 1027 
Figure 8. The effect of IL-10 treatment on MoDC levels of phagocytosis.  The ability of 1028 
untreated immature/iMoDC, maturation cocktail treated mature/mMoDC, dexa treated MoDC 1029 
and IL-10 treated MoDC to phagocytose FITC-labelled microsphere particles was assessed. 1030 
Cells were incubated with particles at 4°C as a negative control (blue dots), or at 37°C (red 1031 
dots), for 3 hours before flow cytometric analysis of FITC fluorescence.  Each dot represents 1032 
the percentage of cells fluorescing FITC, indicating phagocytic uptake, in individual 1033 
experiments. Lines represent the mean percentage of cells associated with FITC microsphere 1034 
particles ±SEM. 1035 
 1036 
Figure 9.  qPCR detection of PRRSV replication in MoDC subsets at 16, 24, 48 and 72 1037 
hours post infection. Immature/iMoDC (black), maturation cocktail treated mature/mMoDC 1038 
(dark blue), dexa treated MoDC (light blue) and IL-10 treated MoDC (orange), were 1039 
infected with PRRSV Lena using an m.o.i of 0.1.  Viral RNA was extracted from cells at 1040 
either 16, 24, 48 or 72 hours p.i and a TaqMan qPCR with an 18S endogenous control was 1041 
used to obtain Ct values.  ΔΔCt represents difference between Ct at 2 hours p.i (time zero) 1042 
and Ct at each time point p.i, both normalized to 18S. Bars represent mean ΔΔCt +SD. 1043 
 1044 
Figure 10. PRRSV replication in MoDC supernatant between 16 and 72 hours p.i. 1045 
Immature/iMoDC (black), maturation cocktail treated mature mMoDC (dark blue), dexa 1046 
treated MoDC (light blue) and IL-10 treated MoDC (orange) for 24 hours before infection 1047 
with PRRSV Lena using an m.o.i of 0.1. Viral RNA was extracted from cell supernatant at 1048 
16, 20, 24, 36, 48 or 72 hours p.i, and TaqMan qPCR was used to obtain Ct values. ΔCt 1049 
represents difference between Ct at 2 hours p.i (time zero) and Ct at each time point p.i. Bars 1050 
represent mean ΔCt +SD. 1051 
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Figure S1.  Morphology of MoMØs. 4-day old MoMØs were either left unstimulated, (A), 1052 
or treated for 24 hours with either IFN-γ and LPS to obtain M1-like MoMØs (B) or with IL-4 1053 
to obtain M2-like MoMØs (C). Alternatively, 4 day old MoMØs were treated with either IL-1054 
10 (D), or with dexa (E). Light microscopy photographs were taken after 24 hours with 1055 
cytokines and are representative of 3 independent experiments Magnification is 20X.  1056 
 1057 
Figure S2. Data summarizing flow cytometric analysis of M1 and M2 MoMØ 1058 
endocytosis. The ability of unstimulated MoMØs or MoMØs treated with M1 or M2 1059 
cytokines to endocytose was assessed using APC*-labelled OVA. Cells were incubated with 1060 
OVA at 4°C as a negative control (blue dots), or at 37°C (red dots), for 1 hour before flow 1061 
cytometric analysis of APC* fluorescence. Dots represent individual experiments, showing 1062 
the percentage of cells fluorescing APC*, indicating endocytic OVA uptake. Lines represent 1063 
mean percentage of cells associated with OVA-APC* ±SEM. 1064 
 1065 
Figure S3. Data summarizing flow cytometric analysis of M1 and M2 MoMØ 1066 
phagocytosis. The ability of unstimulated MoMØs or MoMØs treated with M1 or M2 1067 
cytokines to phagocytose was assessed using FITC-labelled microsphere particles. Cells were 1068 
incubated with particles at 4°C as a negative control (blue dots), or at 37°C (red dots), for 3 1069 
hours before flow cytometric analysis of FITC fluorescence. Dots represent individual 1070 
experiments, showing the percentage of cells fluorescing FITC, indicating phagocytic uptake. 1071 
Lines represent mean percentage of cells associated with FITC microsphere particles ±SEM. 1072 
 1073 
Figure S4. Endocytic Activity of MoMØs following dexa and IL-10 treatment. The 1074 
ability of unstimulated MoMØs or MoMØs treated with dexa or IL-10 to endocytose was 1075 
assessed using APC*-labelled OVA.  Cells were incubated with OVA for 1 hour at 4°C 1076 
(blue) or 37°C (red) before flow cytometric analysis of percentages of cells associated with 1077 
APC*-OVA.  Dots represent individual experiments; lines represent mean percentages ± 1078 
SEM.  One-way ANOVA was used to assess significance followed by Bonferroni’s multiple 1079 
comparison test, *p<0.05. 1080 
 1081 
Figure S5.  Phagocytic Activity of Dexa and IL-10 MoMØs. The ability of unstimulated 1082 
MoMØs or MoMØs treated with dexa or IL-10 to phagocytose FITC-labelled microsphere 1083 
particles was measured after 24 hours of treatment with these factors. Cells were incubated 1084 
with microsphere particles for 3 hours, both at 4°C (blue) or 37°C (red) before flow 1085 
cytometric analysis. Dots represent individual experiments, lines represent mean percentages 1086 
±SEM. One-way ANOVA was used to assess significance followed by Bonferroni’s multiple 1087 
comparison test, *p<0.05. 1088 
 1089 
Figure S6. Intracellular PRRSV staining using SDOW-17 in MoMØ subsets.  Monocytes 1090 
were treated with M-CSF for 4 days to generate MoMØs, and either left unstimulated or 1091 
activated with LPS & IFN-γ (M1), IL-4 (M2), dexa or IL-10 for 24 hours before infection 1092 
with PRRSV Lena.  At 20 hours p.i cells were harvested and stained with a LIVE/DEAD 1093 
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Violet stain before being permeabilized and fixed for intracellular staining with α-PRRSV 1094 
antibody SDOW-17 and secondary G1-APC* for detection by flow cytometry.  Cells were 1095 
gated on FSC/SSC (A) before dead cells were eliminated according to LIVE/DEAD Violet 1096 
stain (B).  For negative controls, cells were stained with secondary G1-APC* only (C) and 1097 
with a mouse IgG1 isotype and secondary G1-APC* (D).  SDOW-APC* staining is shown in 1098 
mock infected MoMØs (E) and in unstimulated (F), M1 (G), M2 (H), dexa (I), IL-10 (J) 1099 
treated MoMØs. Data are representative of three independent experiments.  1100 
 1101 
Figure S7. Morphology of MoDCs. Four day old MoDCs were either left untreated, (A), or 1102 
treated for 24 hours with a maturation cocktail containing LPS, IFN-γ, IL-6, TNF-, IL-1 1103 
and PGE2 (B). Alternatively, four day old MoDCs were treated for 24 hours with IL-10 (C) 1104 
or dexa (D). Light microscopy photographs are representative of 3 independent experiments.  1105 
Magnification is 20X 1106 
 1107 
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